Clinical Trial Update: Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dasatinib in patients with chronic myeloid leukemia in chronic phase; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: UNKNOWN